Sudeep Pharma IPO Analyzed
Sudeep Pharma, a company that makes ingredients for medicines, is trying to go public – this is called an IPO. The chance to buy shares in the company closes today, November 25, 2025. Investors have been a little hesitant so far. As of 11:30 AM on Tuesday, people had bid for 98.23 million shares out of the 10.56 million available, meaning the subscription rate was about 9.3 times.
Key Points
- Sudeep Pharma is offering shares to the public for the first time.
- Investors have shown moderate interest in buying these shares.
- Non-Institutional Investors are the biggest buyers, oversubscribing significantly.
- Retail investors and Qualified Institutional Buyers have also shown some interest.
- The IPO aims to raise ₹895 crore through a share sale.
- Shares are expected to list on the NSE and BSE around November 28, 2025.
Non-Institutional Investors – people who aren’t large businesses – were the biggest fans, wanting more shares than they were allowed. They oversubscribed their portion by a huge 26.3 times! Retail investors, who usually buy shares on their own, also showed decent interest, taking up 7.20 times their share of the offering. However, the bigger investors, called Qualified Institutional Buyers (QIBs), were quieter, only subscribing to about 17% of the shares.
Before the IPO, some unofficial markets were saying Sudeep Pharma’s shares were trading at ₹679, which is 14.5% higher than the expected price range. This “grey market premium” suggests people thought the shares would be worth more when they were officially listed. Investment banks like Reliance Securities and Geojit Investments gave the IPO a “Subscribe” rating, meaning they thought investors should buy the shares.
Geojit Investments said the company is strong and reliable, and well-positioned for growth. They pointed to good performance and a plan to make battery-grade minerals, which are important for electric car batteries. This rating is for investors who plan to hold the shares for a long time.
Sudeep Pharma wants to raise ₹895 crore by selling shares to the public. They’ll use the money to buy new equipment for their factory and for other general business costs. Investors can buy shares in lots of 25, and the price range is from ₹563 to ₹593. Once the shares are sold, they’ll be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
The process of deciding who gets the shares (the “basis of allotment”) will happen on Wednesday, November 26, 2025. If you’re lucky enough to be selected, you’ll receive your shares by Thursday, November 27, 2025, and the shares are expected to be listed around November 28, 2025.
The most important thing to remember is that investing in IPOs can be risky, so do your research before you buy.
